EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Detection of the interactions of tumour derived extracellular vesicles with immune cells is dependent on EV‐labelling methods

Luisa Loconte iD, Davinia Arguedas, Rojbin El iD, Alix Zhou, Anna Chipont, Lea Guyonnet, Coralie Guerin, Ester Piovesana iD, José Luis Vázquez-Ibar iD, Alain Joliot iD, Clotilde Théry iD, Lorena Martín-Jaular iD

Journal of Extracellular Vesicles · 2023-12 · 12 (12)

DOI: 10.1002/jev2.12384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 30.11.2023. Verfasst von Luisa Loconte und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France. Hauptthemen laut MEDLINE: Extracellular Vesicles. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, H2020 Marie Skłodowska-Curie Actions, Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell‐cell communication within the complex tumour microenvironment is critical to cancer progression. Tumor‐derived extracellular vesicles (TD‐EVs) are key players in this process. They can interact with immune cells and modulate their activity, either suppressing or activating the immune system. Deciphering the interactions between TD‐EVs and immune cells is essential to understand immune modulation by cancer cells. Fluorescent labelling of TD‐EVs is a method of choice to study such interaction. This work aims to determine the impact of EV labelling methods on the detection by imaging flow cytometry and multicolour spectral flow cytometry of EV interaction and capture by the different immune cell types within human Peripheral Blood Mononuclear Cells (PBMCs). EVs released by the triple‐negative breast carcinoma cell line MDA‐MB‐231 were labelled either with the lipophilic dye MemGlow‐488 (MG‐488), Carboxyfluorescein diacetate, succinimidyl ester (CFDA‐SE) or through ectopic expression of a MyrPalm‐superFolderGFP reporter (mp‐sfGFP), which incorporates into EVs during their biogenesis. Our results show that these labelling strategies, although analysed with the same techniques, led to diverging results. While MG‐488‐labelled EVs incorporate in all cell types, CFSE‐labelled EVs are restricted to a minor subset of cells and mp‐sfGFP‐labelled EVs are mainly detected in CD14+ monocytes which are the main uptakers of EVs and other particles, regardless of the labelling method. Furthermore, our results show that the method used for EV labelling influences the detection of the different types of EV interactions with the recipient cells. Specifically, MG‐488, CFSE and mp‐sfGFP result in observation suggesting, respectively, transient EV‐PM interaction that results in dye transfer, EV content delivery, and capture of intact EVs. Consequently, the type of EV labelling method has to be considered as they can provide complementary information on various types of EV‐cell interaction and EV fate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesHumansLeukocytes, MononuclearSuccinimidesCell LineFluoresceins

Stichwörter der Autor:innen

extracellular vesiclesimmune cellslabellinguptake

Substanzen

Succinimides5-(6)-carboxyfluorescein diacetate succinimidyl esterFluoresceins

Autor:innen und Institutionen

  • Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.
  • Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Sapienza' University of Rome, Rome, Italy.
  • Institut Curie centre de recherche, CurieCoretech Extracellular Vesicles, Paris, France.
  • Institut Curie centre de recherche, CurieCoretech Cytometry Platform, Paris, France.
  • Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France.

ORCID-Profile: Luisa Loconte, Rojbin El, Ester Piovesana, José Luis Vázquez-Ibar, Alain Joliot, Clotilde Théry, Lorena Martín-Jaular

Förderung

  • NCI NIH HHS
  • H2020 Marie Skłodowska-Curie Actions
  • Agence Nationale de la Recherche
  • Labex
  • Institut National Du Cancer
  • Fondation ARC pour la Recherche sur le Cancer

Zitieren

APA

Loconte, L., Arguedas, D., El, R., Zhou, A., Chipont, A., Guyonnet, L., Guerin, C., Piovesana, E., Vázquez-Ibar, J. L., Joliot, A., Théry, C., & Martín-Jaular, L. (2023). Detection of the interactions of tumour derived extracellular vesicles with immune cells is dependent on EV‐labelling methods. Journal of Extracellular Vesicles, 12(12). https://doi.org/10.1002/jev2.12384

Vancouver

Loconte L, Arguedas D, El R, Zhou A, Chipont A, Guyonnet L, et al. Detection of the interactions of tumour derived extracellular vesicles with immune cells is dependent on EV‐labelling methods. Journal of Extracellular Vesicles. 2023;12(12). doi:10.1002/jev2.12384

BibTeX
@article{Loconte2023,
  author = {Loconte, Luisa and Arguedas, Davinia and El, Rojbin and Zhou, Alix and Chipont, Anna and Guyonnet, Lea and Guerin, Coralie and Piovesana, Ester and Vázquez-Ibar, José Luis and Joliot, Alain and Théry, Clotilde and Martín-Jaular, Lorena},
  title = {Detection of the interactions of tumour derived extracellular vesicles with immune cells is dependent on EV‐labelling methods},
  journal = {Journal of Extracellular Vesicles},
  year = {2023},
  volume = {12},
  number = {12},
  doi = {10.1002/jev2.12384}
}
Kostenlos starten →